Enhanced prognostic evaluation of diffuse large B‐cell lymphoma: A comprehensive surveillance study incorporating Epstein–Barr virus infection status and immunohistochemical markers

Emerging biologic subsets and new prognostic markers are significantly important for aggressive diffuse large B‐cell lymphoma (DLBCL). Nevertheless, the high cost of testing limits the availability of these tests in most hospitals, thus making prognostic judgment based on basic immunohistochemical t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2024-08, Vol.96 (8), p.e29834-n/a
Hauptverfasser:	Zeng, Meichun, Jia, Qingjun, Chen, Jingjing
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Biomarkers Biomarkers, Tumor diffuse large B‐cell lymphoma DNA viruses DNA, Viral double expression Epstein-Barr virus Epstein-Barr Virus Infections - diagnosis Epstein-Barr Virus Infections - virology Epstein–Barr virus‐encoded small RNA Female Gene expression Germinal centers Health services Herpesvirus 4, Human - genetics Herpesvirus 4, Human - isolation & purification Hospitals Humans immunohistochemistry Immunohistochemistry - methods Lymphoma Lymphoma, Large B-Cell, Diffuse - diagnosis Lymphoma, Large B-Cell, Diffuse - virology Male Medical prognosis Middle Aged Patients Prognosis Proto-Oncogene Proteins c-bcl-2 - analysis Proto-Oncogene Proteins c-bcl-2 - genetics Retrospective Studies RNA viruses Surveillance Viruses Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!